Nalaganje ...
Mednarodni projekti vir: SICRIS

ADVANCE - Educating the next generation of Advanced Therapy (ATMP) professionals and advancing ATMP development

Raziskovalci (2)
št. Evidenčna št. Ime in priimek Razisk. področje Vloga Obdobje Štev. publikacijŠtev. publikacij
1.  12443  dr. Irena Mlinarič Raščan  Farmacija  Nekdanji/sekundarni vodja  2019 - 2022  533 
2.  34512  dr. Dunja Urbančič  Farmacija  Raziskovalec  2019 - 2022  59 
Organizacije (1)
št. Evidenčna št. Razisk. organizacija Kraj Matična številka Štev. publikacijŠtev. publikacij
1.  0787  Univerza v Ljubljani, Fakulteta za farmacijo  Ljubljana  1626973  17.186 
Povzetek
THE VISION & MISSION OF EATRIS Our vision is to make the translation of scientific discoveries into medical products more effective to improve human health and quality of life. Our mission is to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes for society. WHAT IS EATRIS? EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. EATRIS is what is known as an ‘ERIC’, which is a non-profit European Research Infrastructure Consortium. This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest. ‘EATRIS’ has been the acronym of the European Advanced Translational Research Infrastructure in Medicine since the formation of the organisation in 2007. In November 2013, EATRIS became the first biomedical science infrastructure to receive European Research Infrastructure Consortium status, established by the European Commission. WHAT DOES EATRIS DO? EATRIS provides access to a vast array of pre-clinical and clinical expertise and facilities that are available within 144+ top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics.  Solutions are developed in the fields of advanced therapy medicinal products, imaging and tracing, small molecules, vaccines and biomarkers. Our research infrastructure offers a broad range of research services for both academia and industry across various research fields. In addition, we work with public funding agencies, charities and policy makers with tailored actions to help improve the translational research and innovation ecosystem.  We also provide regulatory services, training and education and mentoring. Find out more about our services here.
Zgodovina ogledov
Priljubljeno